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Abstract 
 
Significance: Erythrocyte hemoglobin and myocyte myoglobin, although 
primarily oxygen carrying proteins, have the capacity to do redox chemistry. 
Such redox activity in the wider family of globins now appears to have important 
associations with the mechanisms of cell stress response. In turn an 
understanding of such mechanisms in vivo may have a potential in the 
understanding of cancer therapy resistance and neurodegenerative disorders 
such as Alzheimer’s. Recent Advances: There has been an enhanced 
understanding of the redox chemistry of the globin superfamily in recent years, 
leading to advances in development of hemoglobin-based blood substitutes and 
in hypotheses relating to specific disease mechanisms. Neuroglobin and 
cytoglobin have been linked to cell protection mechanisms against hypoxia and 
oxidative stress, with implications in the onset and progression of 
neurodegenerative diseases for neuroglobin and cancer for cytoglobin. Critical 
Issues: Despite the advances in the understanding of the redox chemistry of 
globins, the physiological roles of many of these proteins still remain ambiguous 
at best. Confusion over potential physiological roles may relate to multifunctional 
roles for globins which may be modulated by surface exposed cysteine pairs in 
some globins. Such roles may be critical in deciphering the relationships of these 
globins in human diseases. Future Directions: Further studies are required to 
connect the considerable knowledge on the mechanisms of globin redox 
chemistry in vitro with the physiological and pathological roles of the globins in 
vivo. In doing so, new therapies for neurodegenerative disorders and cancer 
therapy resistance may be targeted. 
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Introduction 
 
The redox chemistry of hemoglobin has long been considered an undesired side 
reaction, leading to the formation of radicals, vasoactive compounds and 
cytotoxicity. Yet this redox chemistry is an inherent nature of the biochemistry of 
all globins. Recent research into the redox activity of hemoglobin and 
investigations into the nature of the biological activity of other members of the 
hemoglobin superfamily have presented insights into the diversity and 
complexity of globin-associated redox chemistry. This redox chemistry relates 
not only to pathological mechanisms, that some might consider to be the main 
role of such reactions, but also potential physiologically relevant functions. What 
follows is a brief introduction to the redox chemistry of the hemoglobin 
superfamily and the relationship between this chemistry and physiological and 
pathological mechanisms that have been developed over the past few decades.  
The mechanisms of the redox activity of globins have relevance in 
bacteria, plant and animals and the understanding of proteins from one class of 
globins may inform on the redox functions of others. This may be of particular 
relevance to the understanding between potential links between the redox 
activity of vertebrate globins and mechanisms of disease and cell protection. For 
example, there has been a realization of the importance of the redox chemistry 
of cytoglobin (Cygb) in cancer therapy resistance and neuroglobin (Ngb) in 
protection against neurodegenerative diseases. However the mechanisms that 
control possible redox functions of these globins remain unclear. Potential 
multifunctional roles of globins may provide an answer to conflicting reports 
concerning redox functions of globins. Mechanisms that can modulate the 
activity of the globins in vivo, such as oxidation of cysteines, will be explored. In 
addition, true multifunctional globins such as dehaloperoxidase (DHP) will be 
examined to give insights into the potential mechanisms of protein function 
modulation in vivo. 
 
Peroxidase activity of hemoglobin and myoglobin in disease. 
 
During the pioneering work on the mechanisms of peroxidase activity conducted 
during the 1950s and 60’s, myoglobin (Mb) and hemoglobin (Hb) provided an 
ideal model system for study. The ease of obtaining significant quantities of the 
protein and the slow reaction between H2O2 and these respiratory heme proteins 
provided an opportunity to follow the reaction in detail (35,36,57). The reaction 
between Mb or Hb and H2O2 was termed (and frequently still is) a “pseudo-
peroxidase” activity as it was not considered that these reactions were relevant 
in vivo. However, many now consider globins to be true peroxidases with specific 
biological roles for this activity. This reaction generates a hyper valent ferryl 
heme iron from both ferrous and ferric oxidation states with a protein based 
radical if initiated from the ferric state: 
P-Fe2+ + H2O2 ↔ P-[Fe4+=O2-]2+ + H2O  (Eq 1). 
P-Fe3+ + H2O2 ↔ P●+-[Fe4+=O2-]2+ + H2O   (Eq 2). 
Where P represents protein and P●+ a protein cationic radical. For peroxidases 
such as ascorbate peroxidase and catalase, this radical is stabilized on the 
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porphyrin or nearby amino acid. For Mb and Hb this reactivity occurs mainly 
under uncontrolled pathological conditions with the radical migrating throughout 
the protein or onto unintended substrates, with the ferryl (equivalent to 
compound II) also able to initiate oxidation of substrates such as lipids For 
reviews on this subject see (86,97).  The reaction between Mb or Hb and lipid 
peroxides also generates ferryl heme iron and radical species. However, being a 
one electron acceptor, the radical products of lipid-based peroxides are the lipids 
themselves, leading to a potential cascade of lipid oxidation reactions and potent 
cell signaling molecules (49,68,96). 
The redox chemistry of Mb or Hb is suppressed within the myocyte and 
erythrocyte respectively and generally only become apparent following myocyte 
injury and/or hemolysis. This is particularly relevant for erythrocytes due to the 
constant process of hemolysis in the blood stream. There are numerous systems 
for dealing with this undesired redox chemistry in the blood plasma including 
haptoglobin (Hp) and hemopexin (24,98). These proteins sequester free 
hemoglobin and free heme respectively, providing a defense against 
hemoglobin-mediated oxidative damage during intravascular hemolysis. The 
binding of alpha-beta dimers of Hb to Hp also appear to inhibit the damaging 
effects of Hb peroxidase activity, not by preventing the primary reactivity of the 
globin with peroxidase, but by limiting the reactivity of the high oxidation state 
of the protein (17). Here the ferryl heme iron is stabilized, increasing the steady 
state of ferryl heme iron. Ferryl stabilization is accompanied by an increase in 
the amount of the peroxide-induced tyrosine free radical on the beta chain 
(βTyr145). Thus Hp may function to protect against vasculature damage by 
preventing oxidation of species that initiate undesirable free radical chain 
reactions without altering the reactivity of Hb with small exogenous ligands such 
as O2, NO and H2O2 (17). Extensive hemolysis can overwhelm the Hp and heme 
sequestering proteins and Mb, released from muscle damage (rhabdomyolysis), 
cannot be sequestered by Hp, leading to kidney damage (68). The redox activity 
of alpha Hb can also be suppressed when bound to its chaperone protein alpha 
hemoglobin stabilizing protein (67). The decrease in peroxidase activity results 
from the change in heme coordination from penta- to hexa- when alpha Hb is 
bound to the chaperone protein (30,44). Thus the chaperone prevents oxidation 
of the protein, and hence protein destabilization, before formation of α2β2 or α2γ2 
tetramers.  
The high oxidation state of the iron (Fe4+) is difficult to detect directly in 
vivo due to the transient nature of the hyper-valent ferryl heme iron and 
protein-based radical generated concurrent with ferryl heme. In addition the 
reactions they can potentially promote, that of free radical-mediated oxidation, 
can be sourced from a variety of alternative reaction systems such as Fenton 
chemistry or cyclooxygenase enzymes. Nonetheless, isolated ischemic rat hearts 
showed significant oxidation of Mb to the ferryl state by residual H2O2(3). The 
ferryl heme iron and protein radical are highly oxidizing compounds, damaging 
proteins, DNA and small molecules, however lipids are particularly vulnerable to 
oxidation. This prooxidant activity of Hb is linked to a number of disease states 
including atherosclerosis (84). The formation of ferryl Mb or Hb may not be 
preventable, with ferryl Hb associated free radical observable in normal blood by 
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EPR spectroscopy (110). However, the ferryl iron and the protein radical can be 
safely dealt with in the environment of the myocyte or erythrocyte by various 
electron donating antioxidant agents such as ascorbate and urate (18). It is of 
note that iron chelators such as desferrioxamine and deferriprone, ameliorators 
of oxidative damage, can efficiently reduce the ferryl heme iron to the ferric in 
addition to their prevention of Fenton chemistry by labile iron (16,90). Therefore 
it is difficult to determine the mechanism of any ameliorative effects obtained 
from the use of such chelators in vivo. That is, whether the mechanism of the 
antioxidant effects of these chelators are by donation of electrons to the high 
oxidation states of hemoglobin or by preventing the Fenton chemistry of non-
heme iron.  
A covalent link between the heme and protein is formed from heme 
undergoing a ferric-ferryl redox cycle under acidic conditions (14,88,94). 
Although noted as a stable green-colored by-product of ferric-ferryl redox cycling 
over half a century ago, it was considered primarily as a curiosity with no 
obvious biological relevance (35). However, as a stable and specific product of 
Mb/Hb redox cycling, it had the potential to fulfil the role as a marker of their 
previous redox chemistry in vivo. Heme-to-protein cross-linked Mb has been 
detected following rhabdomyolysis (muscle damage) in the kidney of animal 
models and urine of human patients (48,49,68). Such covalent modifications of 
Hb has also been detected following subarachnoid hemorrhage in the 
cerebrospinal fluid (91). This is direct evidence of the involvement of these 
globins in redox chemistry, which appears to occur whenever the globin 
becomes separated from its normal reductive environment. Potent vasoactive 
lipid oxidation products, such as isoprostanes, are generated during acute kidney 
injury following rhabdomyolysis and during delayed vasospasm in the 
cerebrospinal fluid. Isoprostanes can be formed in vitro by the peroxidase 
activity of Mb/Hb on cell tissue or low density lipoproteins (8,68,92). Hence 
globin redox chemistry is a likely origin of these vasoactive compounds in vivo, 
particularly when combined with the evidence that the globins undergo redox 
cycling by the cross-linking in the same disease tissue. It should be noted that 
Fenton chemistry can also lead to production of vasoactive products (130,131) 
and hence the significance of the finding of such heme to protein cross-links in 
vivo is debatable.  
Other covalent modifications are noted in human Hb peroxidase redox 
activity. Both adult and fetal show extensive oxidative modifications to α and 
beta/gamma chains, although the β/γ chain are more prone to oxidative 
modifications than that of α chain (55). In a variant of Hb (γ-Val67 to Met, Hb 
Toms River) incorporation of labeled oxygen from H218O2 to the methionine 
converts the amino acid into asparagine (106). Irreversible oxidation of β Cys93 
occurs, up to two thirds of β Cys93 is oxidized with ~10 fold excess of H2O2 (55). 
This modification is even more extensive in sickle cell Hb. Other ‘hotspots’ of 
amino acid modifications include β Trp15, Trp37, Met55 and Cys112, as well as α 
Tyr24, Met32, Tyr42, Met76 and Cys104 (55). These structural instabilities from 
such modification can lead to heme loss and oxidative damage to mitochondria.  
Ferryl Hb also has important reported effects on inflammation and cell 
adhesion molecules. Heme released from damaged globins is a powerful pro-
6 
 
oxidant, qualifying it as a danger-associated molecular pattern (DAMP) molecule, 
increasing the  activation of Nrf2 and HO-1 (125). However, Hb itself has 
reported pro-inflammatory effects, targeting vascular endothelial cells, inducing 
the expression of pro-inflammatory genes in endothelial cells, including 
activation of the NF-κB family of transcription factor cell adhesion molecules 
such as E-selectin, Icam-1, and Vcam-1 (104). This leads to effects on the actin 
cytoskeleton, disrupting the endothelial cell monolayer. Furthermore, actin 
filament length is also affected in red blood cells, with ferryl Hb decreasing the 
actin polymerization in cells infected with Plasmodium falciparum malaria in vitro 
(20). This effect is enhanced with sickle cell Hb S or Hb C potentially preventing 
the parasite from creating its own actin cytoskeleton within the host cell 
cytoplasm, giving a possible mechanism of protection against the malarial 
parasite. The ferryl form of Hb S also induces oxidative stress in lung epithelial 
cells over that of HbA, attributed to the longer lived ferryl species of Hb S (55). 
However both HbA and HbS induce HO-1 and superoxide production with 
impairment of mitochondrial oxygen consumption.  
The redox chemistry of Hb is also relevant in the development of 
hemoglobin-based oxygen carriers (HBOCs) used as potential blood substitutes 
or oxygen therapeutics. Numerous attempts have been made at generating a 
stable, non-toxic form of cell-free hemoglobin with limited success to date. 
However, these studies have focusing on preventing kidney damage (through 
increasing the size and stability of the protein structure by polymerisation, 
encapsulation or pegylation) and preventing scavenging of nitric oxide (NO) 
(through site-directed mutagenesis) (2,119). These aspects of HBOC chemistry 
are undoubtedly important factors in generating safer HBOCs, however, the 
peroxidatic activity of Hb and HBOCs have only recently been considered to be 
potential factor in taming HBOCs (1,2). One strategy to limit the redox chemistry 
of HBOCs in vivo is to enhance the ability of naturally occurring antioxidants in 
the blood to remove the cytotoxic ferryl form of the hemoglobin by introducing 
electron transfer pathways to the engineered HBOC (vide infra). 
 
Through-protein electron transfer pathways. 
 
Through-protein electron transfer pathways (TPETPs) have the ability to 
accelerate the reduction of the ferryl oxidation state of globins, enhancing the 
safer removal of the cytotoxic forms of hemoglobins by physiological 
concentrations of antioxidants such as ascorbate, urate or even low 
concentrations (micromolar) of iron chelators such as deferiprone. We first 
reported these TPETPs to be naturally occurring in Mb of some species (87), 
noting the potential implications for therapeutic intervention in oxidative stress 
and for engineering more effective blood substitutes. These pathways, 
incorporating redox active tyrosines (Tyr103 in human/horse/sperm whale Mb) 
are able to pass electrons from the reductant to the heme iron more efficiently 
than direct access to the heme pocket (Figure 1). Human hemoglobin alpha 
subunit contains such a TPETP with a redox active tyrosine (α-Tyr42), but the 
beta subunit equivalent position is occupied by a redox-inactive phenylalanine 
(β-Phe41) and hence has no TPETP. The position of Tyr42 in Mb and Tyr103 in α 
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Hb are in similar spatial positions (even though from different helixes) and thus 
appear to perform similarly with regard to rates of electron transfer. 
Mutagenesis can introduce such pathways into the beta chain or remove them 
from the alpha chain, affecting the kinetics of electron donation of the reductant 
to the heme iron accordingly (89). Substitution with other redox active residues 
such as tryptophan do not show TPETP activity (89). At physiological 
concentrations of ascorbate (~50 µM) proteins with the TPETPs can effectively 
enhance ferryl iron reduction up to 12 fold over those without the pathway (89). 
Other serum antioxidants such as uric acid as well as phenols, hydroxyurea and 
iron chelators such as hydroxypyridinone CP20 (deferriprone) can also act as 
ferryl reductants utilizing the TPETP (18,87,89,90). 
A study using a model Mb from Aplysia Fasciata (sometimes referred to as 
Aplysia Limacina, a junior synonym of Aplysia Fasciata) showed that the addition 
of a single tyrosine residues (Phe98Tyr) to generate a TPETP interfacing the 
heme iron and external environment can enhance ferryl reduction up to twelve 
hundred times, two orders of magnitude faster than those found in human Hb 
(93). With the inclusion of a distal histidine (V63H) to more closely mimic the 
redox chemistry of human Hb, the half times of ferryl reduction are altered from 
tens of minutes seen with the V63H Aplysia Mb variant (and human Hb) to sub-
second half times with the V63H/F98Y Aplysia Mb mutations (93). Currently the 
reason for the two orders of magnitude difference of the electron transfer rates 
of engineered Aplysia Mb from A. Fasciata and human Hb are unknown. 
However, it is a current goal of research to incorporate such high rate TPETPs 
into recombinant human hemoglobin as a potential HBOC (103). It is not clear 
whether these mechanisms of ferryl reduction relate to globins where the high 
oxidation state of the globin may have physiological relevance. It is noteworthy 
however that some globins such as Hell’s Gate globin-I, a thermophilic protein 
structurally similar to Ngb in Methylacidiphilum infernorum have multiple 
tyrosine residues within the heme pocket (80,112). Whether this high tyrosine 
content relates to thermostability or redox activity remains to be seen. 
 
Physiological role for the redox chemistry of neuroglobin and cytoglobin 
in health and disease? 
 
It is evident that the redox chemistry of vertebrate Hbs and Mbs, primarily 
involving the peroxidase activities of these proteins, relates to conditions of 
pathology where such redox activity is undesirable. However the redox activity 
of globins appears to be of potential benefit, particularly to cell survival under 
conditions of stress. In the last two decades the family of globins have expanded 
considerably, with particular interest in human globins Ngb and Cygb and the 
potential functions and relations to cell protection in disease states. Both Ngb 
and Cygb are up-regulated under hypoxia suggesting potential oxygen 
binding/sensing, NO scavenging or nitrite reductase functions. However, both 
proteins also appear to play a role in oxidative stress mechanisms and maybe 
involved in cell signaling or cell protection. Recent research has led to the 
proposal of numerous potential biological functions under normal cellular 
conditions and in stress responses. Due to this large and diverse literature there 
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is currently uncertainty with regard to the primary function of these proteins 
(28,72,81,86,101,123). The molecular mechanisms of are still poorly 
understood, particularly with respect to their functionality in vivo. What follows 
focuses on the current opinions relating to the biological activity of Ngb and 
Cygb that have been advanced over the last few years. 
 
Neuroglobin and Neuroprotection. 
Discovered in 2000, Ngb is the third globin to be found in humans after Hb and 
Mb (12). A hemoglobin with typical 3-on-3 α-helical fold of both Mb and Hb, Ngb 
differs from these protein by way of the geometry of the heme iron coordination. 
In the absence of exogenous ligands, the distal histidine is directly coordinated 
to the iron, making the ferric and deoxy ferrous heme iron low-spin 
hexacoordinate, coordinated by both proximal and distal histidines. The oxygen 
binding proteins Hb and Mb are high spin pentacoordinate in the absence of 
exogenous ligands, with the distal histidine unable to form a bond with the iron 
and instead forms a hydrogen bond to stabilize oxygen binding (65,74). 
Nonetheless Ngb has an affinity for oxygen of ~1 torr, similar to that of Mb 
(12,81) with a proposed function of the temporary oxygen storage (25). The 
physiological function of Ngb may be related to its ability to react rapidly with 
NO in nervous tissue, functioning as an NO dioxygenase enzyme (Figure 2). This 
could be important in maintaining the function of neuron mitochondria, 
preventing mitochondrial poisoning by NO (54,118). However, this reactivity 
requires the Ngb to be in the oxyferrous form with high concentration of oxygen 
in neuronal cells, a supposition that is highly debated (4,9,12,25,116). An 
alternative view is that Ngb may function as a nitrite reductase, generating NO 
under conditions of oxidative or hypoxic stress (Figure 2) (83,114), similar to 
that proposed for Hb under similar conditions (19,37,63). Nitrite reductase 
activity has been proposed to underlie neuroprotective signaling under hypoxic 
conditions through NO production from nitrite (114), although Hb nitrite 
reductase activity is greatest when the protein is at its p50 for O2 saturation due 
to allosteric modulation (37,38). It has also been proposed that Hb can form 
dinitrogen trioxide (N2O3), dissociating into NO and NO2 (37,51). Such an 
application for this biochemistry of Ngb has not been elucidated, but as an 
uncharged molecule N2O3 can diffuse through the cell membrane which could 
potentially act as a transport for NO to the endothelium (13,51). 
Low concentrations of Ngb in brain neurons associated with increased risk 
of Alzheimer’s disease (111). However, Ngb has also been shown to be 
upregulated in Alzheimer’s disease (108). It has been proposed that Ngb 
prevents cytochrome c from forming apopotosomes, averting neuron cell death 
(85). Another proposal is that Ngb functions as an oxidative-stress responsive 
sensor, with oxidized ferric Ngb inhibiting GDP dissociation from the alpha 
subunit of heterotrimeric G protein, thereby acting as a guanine nucleotide 
dissociation inhibitor (GDI) (122,124). The GDI activity of Ngb correlated with its 
neuroprotective activity during oxidative-induced structural changes to alpha G 
protein (123). However, it is of note that Human Ngb but not Zebrafish Ngb 
exhibits such GDI activity (123), suggesting a more complex and diverse nature 
of this protein. 
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Whatever the biochemistry of Ngb in vivo, it is clear that the primary 
function of this highly conserved protein is related the protection of neuronal 
activity (10) and that more research is required for a more complete 
understanding of the molecular mechanisms of this protein in vivo and its 
potential role in protection against stress-related cell damage and 
neurodegeneration. 
 
Cytoglobin, tumor suppression and cancer therapy resistance. 
Cygb is the fourth globin to be found in humans and discovered in 2001. Initially 
referred to as stellate cell activating protein (56) and histoglobin (115), the 
heme pocket structure of Cygb has similar in nature to Ngb, possessing a 
hexacoordinate iron ligation in the absence of exogenous ligands (22). However, 
the distal histidine coordination of Cygb appears to be weaker than observed in 
Ngb, with partial heme penta-coordination observed in the structure of one of 
the Cygb subunits of the homodimer (22). This pentacoordinate-like nature of 
the Cygb can be further enhanced by increasing the distal histidine off-rate, 
observed in the monomeric form of the protein with an intramolecular disulfide 
bond (7). There have been many suggested functions of Cygb. Cygb has been 
proposed to act as an oxygen diffusion proteins similar to Mb, based on 
observations of increased expression of Cygb in heart and muscle in amphibians 
that lack Mb (126). Cygb has also been proposed to function as an NO 
scavenger, from observed high rates of NO consumption and its fast re-reduction 
by ascorbate and cytochrome P450 reductase (64). This proposal of NO 
consumption has also been enhanced by increased NO levels and decreased 
intracellular nitrate production from partially silenced Cygb (41). However, the 
most intriguing property of the protein appears to relate to cell protection 
against oxidative stress and potential relationship with carcinomas. However, 
this is a double-edged-sword as Cygb appears to function not only as a tumor 
suppressor but also protects hypoxic tumors against therapy. The potential role 
of Cygb in cancer suppression and hypoxic tumor protection has been recently 
reviewed (15). 
Promotor methylation downregulates Cygb expression as observed in oral 
cancer (100), in head and neck squamous cell carcinoma (101) and in non-small 
cell lung carcinoma (127), indicating that the gene for Cygb functions as a tumor 
suppressor. Furthermore, methylation of the gene for Cygb is able to 
discriminate patients with and without lung cancer, using biopsies and sputum 
sample (102). Cygb deficient mice has been found to promote carcinogenesis in 
lung and livers when exposed to carcinogens such as diethylnitrosamine (113). 
Cygb loss may contribute to tumor recurrence and a worse prognosis in gliomas 
and may serve as an independent predictive factor for prognosis of glioma 
patients (128).  
Expression of mRNA for Cygb was found to correlate with hypoxia inducing 
factor 1-alpha (HIF-1α) in squamous cell carcinoma (101) indicating that 
expression of Cygb is regulated by hypoxia. Increased expression of this gene 
correlates with clincopathological measures of a tumor’s biological aggression 
(101). The Cygb gene also has a protective role for proliferating keratinocytes 
under normoxic conditions and protects against exogenous hydrogen peroxide 
10 
 
oxidative insults (59). This study shows that ∆Np63, a p63 transcription factor 
protein, targets the Cygb gene leading to upregulation of Cygb and inhibition 
oxidative stress-induced apoptosis in keratinocytes. This also present in lung and 
breast cancer cell lines, indicating that Cygb-mediated scavenging of reactive 
oxygen species may also have a role in epithelial tumors and lung cancers. 
Furthermore, in human lung cancer data sets, the interaction of ∆Np63 with 
Cygb gene significantly predicts reduction of patient survival (59). From the 
studies of Cygb and cancer prevention and promotion it is clear that Cygb has a 
bimodal tumor suppressors and oncogene functions (73). 
Although the relationship of Cygb and with tumors has seen the greatest 
attention in recent years, other properties of Cygb also involve protection of the 
liver from fibrosis. Stemming from the protein’s original naming in 2001 (56), 
Cygb is expressed in stellate cells but not fibroblasts (70), and as such the 
expression of Cygb can distinguish stellate cells from portal myofibroblasts in 
damaged liver. Furthermore, overexpression of Cygb in rat hepatic stellate cells 
inhibits their differentiation into myofibroblast-like cell phenotypes when 
challenged with oxidative stress (129). Similarly Cygb anti-fibrosis activity on rat 
livers decreased thioacetamide-induced liver fibrosis, which was proposed to 
involve apoptosis induction from activation of the caspase cascade (46). 
 
Controlling protein function through cysteine oxidation. 
As described above, the biochemistry of the heme can potentially promote 
the scavenging or formation of NO as observed in vitro for Hb, Ngb and Cygb 
(Figure 2). In addition to this biochemistry surface-exposed cysteine residues 
have the capacity to generate complexes with NO, forming S-nitrosothiol. This 
has been observed for human Hb in vitro binding NO to the cysteine on the beta 
chain of human hemoglobin (βCys93) to form Hb-SNO (39). The relevance for 
Hb-SNO for hypoxia response remains a widely debated subject and only 
discussed in brief here (37,39,53,79,121,132). Roles for this NO binding 
chemistry have been suggested to be a mechanism for the regulation of hypoxic 
vasodilation. This cysteine is highly conserved in the mammal and avian species 
(and is also present in fetal Hb as γCys93), so much so that the only other 
amino acids that are as highly conserved as β/γ Cys93 are a histidine and 
phenylalanine involved in heme stabilization (132). The relevance of hemoglobin 
forming and carrying NO relates to conditions of hypoxia, with the hypothesis 
that hypoxic conditions trigger the release of NO to induce a vasodilation 
response. Indeed mice with a βCys93Ala mutation appear to have deficient 
hypoxic vasodilation and enhanced mortality with transient hypoxia (132). Thus 
βCys93 appears to have an antioxidant role, protecting mice against 
lipopolysaccharide-induced reactive oxygen species and hypertension (121).  .  
Like Hb, Ngb and Cygb also possess Cys residues that are surface exposed 
and have the potential to form SNO complexes. In vitro data shows that Cygb 
and Ngb can form SNO complexes, for example when reacting with nitrite under 
anaerobic conditions (83), but the relevancy of this chemistry in vivo has yet to 
be explored in detail. However, the cysteines of Ngb and Cygb are in pairs, 
promoting the view that the formation of disulfide (cystine) bonds are important 
in functional regulation of the proteins. Such dicysteine bridges can be 
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intermolecular, forming dimers (dimerS-S), intramolecular, forming monomers 
(monomerS-S) or reduced to free sulfhydryl (monomerS-H). These dicysteine 
bridges can alter the structure and ligand binding properties of the active site of 
both Ngb and Cygb and in doing so potentially regulate its function in vivo. Both 
Ngb and Cygb show significant dependence of their biophysical properties on the 
redox state of their surface-exposed cysteines (120). These cysteines pairs 
(Cys38/Cys83) in human Cygb (Figure 3) are highly conserved throughout 
mammals, but not in other vertebrates. Cys46/Cys55 in human Ngb (Figure 3) is 
more widely found in other vertebrates. Numerous studies have shown that 
these cysteine pairs affect both exogenous and endogenous ligand binding to the 
heme iron, with supposition that the redox state of the cell modulates the ligand 
affinities of these proteins (7,42).  
Recombinant expression of Ngb primarily generates the protein with a 
disulfide bond between Cys46 and Cys55 (monomerS-S) located on the CD loop 
region of the protein (42). The protein in this monomerS-S form shows high NO 
dioxygenase and nitrite reductase activities but negligible peroxidase-like 
activities (71,114). This, in part, has reinforced the view that Ngb functions 
primarily as cytoprotective role against NO-induced impairment of mitochondrial 
metabolism (105). However, the state of the cysteine pair also appears to 
modulate nitrite reductase activity, with an enhanced formation of NO when the 
protein in the monomerS-S conformation and proposed to be a stress responsive 
mechanism (114). Breaking the disulfide bond leads to a large decrease in the 
oxygen affinity of Ngb, linked to a decrease in the histidine dissociation rate 
(43), Figure 4. Stabilization the hexacoordinate form with in the monomerS-H 
protein has also been proposed to be the mechanism of slowing the nitrite 
reductase activity of Ngb (114). The crystal structure of the monomerS-S form of 
Ngb was difficult to generate, with original published crystal structures of a 
double cysteine mutant (82). Molecular dynamic simulations suggested that the 
formation of a disulphide bond changes the CD loop from strand to a helix 
structure, structuring the active site and acting as a redox control for Ngb 
function (69). The predicted structural changes of the CD loop was confirmed 
with a recent publication of the structure of the wild type protein in the 
monomerS-S form (40). Ngb is presumed to be monomeric in vivo, however, 
dimers have been reported from studies using retinal neurons (77) and that such 
dimers are likely to be disulfide-linked (60). Hence elucidating conditions where 
the protein is monomer or dimer and the effects of these conformations on cell 
signaling pathways is of particular importance when considering the 
physiological role of the protein. 
Recombinant expression of Cygb in E.coli tends to lead to the formation of 
mixture of three forms of conformations of protein depending on the redox state 
of two surface exposed cysteine residues (Cys38 and Cys83) – (i) dimerS-S with 
two intermolecular disulfide bridges spanning Cys38 on one protein to Cys83 on 
the other protein and vice versa (ii) monomerS-S protein with the intramolecular 
disulfide between the B and E helices and (iii) monomerS-H protein with free 
sulfhydryl (7). Current crystallographic data on recombinant Cygb shows either 
dimerS-S conformation (e.g. PDB structure 1UMO (22)) or monomerS-H 
conformation with free sulfhydryl (e.g. PDB structure 3AG0 (66)) or Cys to Ser 
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mutations (e.g. PDB structure 1V5H(107)). To date no structures of Cygb with 
intramolecular disulfide bond have been published.  
MonomericS-S Cygb show significantly different carbon monoxide (CO) and 
cyanide (CN) ligand affinities compared to monomer with free sulfhydryl or with 
cysteine mutations, showing that ligand binding in both ferrous and ferric 
oxidation states of the protein are affected by the redox state of the cysteine 
residues (117). The dissociation rate for the distal histidine is 1000 fold higher 
with the monomerS-S protein compared to monomerS-H, (6), Figure 4. Thus the 
monomerS-S form of Cygb although still primarily bis-his hexacoordinate in the 
absence of exogenous ligands, possesses properties that are more 
pentacordinate-like compared to the monomerS-H protein. Furthermore, the 
monomericS-S form of Cygb shows higher peroxidase-like activities compared 
with other forms of the protein, oxidizing lipids and lipid membranes more 
efficiently (7). In contrast with this, the dimeric protein with intermolecular 
disulfides or monomer with free thiol shows poor lipid peroxidase activity, 
decreased ligand-binding kinetics and a ridged hexacoordiante nature (6,7).  
Crystal structure of dimerS-S Cygb places the two sulphur atoms some 12 Å 
distant (1V5H) (107), suggesting a significant shift in the B/E helices to 
accommodate the formation of a disulfide bond between the two residues. 
Comparison to crystal structure of Cygb with free sulfhydryl (2DC3) (66) shows 
the two cysteine sulfurs to be some 7 Å closer (Figure 3D). These effects on 
structure are likely to affect the heme pocket geometry on the distal side, 
however, no structural information of the monomerS-S form of the protein is yet 
available other than the ligand binding and reactivity effects described above. 
Nonetheless the question remains what is the form of Cygb in vivo and is this 
modulated by the redox environment of the cell?  
We have previously reported that the conformer state of these cysteines also 
influences lipid-induced structural changes to Cygb (95). This effect is observed 
only in the ferric oxidation state of Cygb and only with the protein possessing an 
intramolecular dicysteine bond (monomerS-S) between Cys38 and Cys83. There 
is no effect of lipids on ferrous Cygb or ferric Cygb dimerS-S or monomerS-H (6,7). 
Thus Cygb appears to have a precise response to molecules such as lipids in an 
oxidized cell environment. Whether this distinctive mechanism of altering protein 
function in vitro has relevancy in vivo is currently unknown. However, the 
interaction between Cygb and fatty acids and lipids is similar to the finding that 
cytochrome c interacts with the lipid cardiolipin, a mechanism that relates to 
caspase-induced apoptotic response to mitochondrial damage (75,78). It is 
possible that the interaction between Cygb and lipids (or other similar 
molecules) has important biological and clinical roles. This, together with the 
observations that the cysteines affect the binding properties of the protein 
suggests a hypothesis that Cygb forms an essential signaling element between 
the cell’s mechanism for sensing stress and its response through upregulation of 
anti-stress proteins (7,95). This hypothesis is summarized in Figure 5. Here the 
oxidation state of the two surface cysteines is key to the protein function. In an 
oxidizing environment, the formation of an intramolecular disulfide bond alters 
the biochemical properties of the protein through changing the protein heme 
pocket structure and hence changes to its redox activity. One consequence of 
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these changes in protein function, namely a high lipid peroxidase activity, would 
lead to production of lipid-based oxidation products. Like that of the formation of 
isoprostanes generated from Hb and Mb under conditions of oxidative stress, 
lipid oxidation would have consequences on cell signaling. This potentially links 
observations that hypoxia and oxidative stress upregulate Cygb production with 
an anti-oxidant response via activation of pathways such as the electrophilic 
responsive element. Electrophilic lipids such 4-hydroxynonenal, prostaglandins 
and isoprostanes are known to activate antioxidant responses such as through 
the Nrf2/ARE (antioxidant responsive element) pathway, inducing upregulation 
of antioxidant proteins or alternative stress responsive pathways (e.g. NF-κB) 
(58,61). This mechanism of linking stress conditions to antioxidant responses 
could in turn be linked with pathological roles of the protein, including the 
observed correlation between increased Cygb gene expression and a hypoxic 
tumor's biological aggression (101) or the cell protection mechanism of 
upregulated Cygb in hypoxic cancer cells protecting hypoxic tumors from 
chemotherapy and radiotherapy (101). The scheme depicted in Figure 5 is based 
primarily from in vitro data, and in vivo observations, any direct link between 
the two is currently unconfirmed and requires further research. 
 
Dehaloperoxidase: The multifunctional hemoglobin. 
When considering the potential functions of mammalian proteins such as Ngb 
and Cygb information about potential physiological functions can be gained from 
examination of similar globins from other organisms such as bacteria and 
annelids. Phylogenetic studies on globins have provided insights into potential 
functions, particularly when the globin is localized in specific organs or is found 
in selected tissue (for recent reviews see (11,99)). However, most of these 
studies focuses on vertebrate globins and one class of globin has been largely 
overlooked until recently. The annelid protein dehaloperoxidase (DHP) shows 
remarkable diversity in its capacity to have multiple functional activities (33). 
Despite its name, the structure of DHP has much more in common with the 
hemoglobin superfamily than it has with the peroxidase superfamily, hence DHP 
is often referred to as dehaloperoxidase-hemoglobin. DHP has a biologically 
relevant peroxidase activity, despite having a typical globin fold structure, 
converting tri-halogenated phenols to quinone products using hydrogen 
peroxide: 
(C6H2)X3OH +H2O2 -> (C6H2)X2O2 +HX +H2O  (Eq 3) 
X=I, Br, Cl or F. 
DHP has the highest known peroxidase activity of any globin. Found in 
Amphitrite ornate, the peroxidase activity is believed to stem from evolutionary 
pressure for the organism to deal with toxic brominated and chlorinated 
compounds produced from the ecosystem in shallow coastal mudflats and 
marine estuaries (31-33,62). Two isoform of the protein; DHP A and DHP B 
differ by 5 amino acids (21,23), but have considerably different peroxidase 
activities. The peroxidase activity of DHP A is lower by one order of magnitude 
than that of horseradish peroxidase, but higher by one order of magnitude than 
sperm whale Mb (76). DHP B is the dominant isoform and has three times the 
peroxidase activity compared to DHP A (33). The peroxidase mechanism 
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involves classic peroxidase activity with the trihalogenated phenol oxidized by 
the radical generated with the hyper-valent ferryl iron. The trihalophenol can be 
oxidized by compound I, taking the radical from the porphyrin, or by compound 
ES, with the radical believed to be associated with a series of tyrosine residues 
(27,29). The second electron comes from the ferryl iron of compound II to form 
ferric DHP and quinone product. Additionally DHP has further activity revealed 
with peroxygenase activity, with oxygen atom transfer to substrate following 
ferryl formation, as well as oxidase activities, with dioxygen consumption in the 
absence of peroxide (5).  
The oxygen affinities for DHP A and B are 4.2 and 2.0 torr respectively 
(33,109), hence DHP appears to have affinities for oxygen in the range for 
usefully delivery of oxygen to the organism. Indeed DHP A and B are the only 
hemoglobin genes identified in A. ornata (45). Sometimes referred to as the 
‘dehaloperoxidase paradox’ the function of DHP as an O2 carrier and a 
peroxidase depends on the oxidation state of the heme iron (34). A structural 
comparison of the heme pocket of DHP compared to erythrocyte Hb and Cygb 
(Figure 6) shows small differences, specifically in the flexibility of the distal 
histidine and the number of aromatic residues in the distal pocket. While DHP 
has features that appear to be unique to the family of globins, both the structure 
and properties of the protein  supports the possibility, indeed a probability, of 
multifunctional roles of other globins, particularly those of Cygb and Ngb.  
 
Summary and future directions 
It is evident that the redox chemistry of hemoglobins, once considered an 
in vitro curiosity, have real physiological and pathological roles. DHP is a true 
multifunctional protein, binding oxygen but also performing peroxidase activities 
vital for the organisms’ survival. Mb, although primarily an O2 binding protein 
has a secondary function as an NO dioxygenase, protecting mitochondria from 
respiratory poisoning by NO. Some view Hb to have a role for carrying NO as 
SNO-Hb, but like Mb definitely shows redox chemistry when outside its normal 
antioxidant environment. These proteins have, or appear to serve, 
multifunctional roles. It is not a great leap in faith to propose that other heme 
proteins such as Ngb and Cygb may also have multi-functional properties, 
involving ligand binding and stress response mechanisms. However, the detailed 
mechanisms of these roles in vivo have yet to be fully explored, particularly in 
respect to linking the in vitro reactivities of the proteins to gene expression 
studies and biochemical studies of the properties of the proteins in vitro.  
The recent discovery in 2012 of a fifth globin in humans, androglobin 
(Adgb), extends the interest in globin redox chemistry and function even further. 
With a 1667 amino acids sequence, Adgb comprises a calpain-like domain, a 
hemoglobin domain and an IQ calmodulin-binding motif (50). The discovery of a 
role of Adgb as an oncogene, promoting cell proliferation has important 
implications in cancer research (52), however, very little is known about this 
multi-domain protein. Phylogenetic studies have gained insights into the 
potential functions of some globins, particularly when appearing in specific 
organs and vertebrate species (11,99). Nevertheless many of the physiological 
functions of globins are yet to be identified, or the observed in vitro functions 
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verified in vivo. The current interest of the role of globins such as Ngb in 
neurodegenerative disease and Cygb cancer therapy resistance make 
deciphering these mechanisms of globins a critical objective for developing an 
understanding of these diseases and potentially discovering novel targets for 
therapy.  
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